BioNTech SE

Healthcare

NASDAQ:BNTX · NASDAQ Global Select

Market Cap $22.90B Beta 1.32 P/E (TTM) -15.8

$90.54 +1.12%

+$1.00 today

52W Low $79.52High $124.00

Vol 1.13M · Avg 0.99M

EPS (TTM)-$4.93

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-15.04%

Period High

$119.34

Period Low

$83.89

Latest

$90.54

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Teva Pharmaceutical Industries Limited

NYSE:TEVA

$40.32B

Natera, Inc.

NASDAQ:NTRA

$30.37B

Biogen Inc.

NASDAQ:BIIB

$29.53B

DexCom, Inc.

NASDAQ:DXCM

$29.08B

Koninklijke Philips N.V.

NYSE:PHG

$25.70B

Royalty Pharma plc

NASDAQ:RPRX

$23.60B

United Therapeutics Corporation

NASDAQ:UTHR

$23.17B

Incyte Corporation

NASDAQ:INCY

$21.68B

STERIS plc

NYSE:STE

$20.26B

Genmab A/S

NASDAQ:GMAB

$15.40B

What is the latest BNTX filing?

The latest filing shown is 6-K dated Jun 8, 2026.

How many recent filings does BNTX have?

Intrinsic Alpha currently shows 20 recent filings for BNTX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.